{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=HTN&page=38", "query": { "condition": "HTN", "page": 38 }, "page_size": 10 }, "pagination": { "page": 38, "page_size": 10, "total_count": 3925, "total_pages": 393, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=HTN&page=39&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=HTN&page=37&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-10T22:34:12.414Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00949884", "title": "Olmesartan Comparison to Losartan in Hypertensive Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "olmesartan medoxomil", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "losartan potassium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 941, "start_date": "2009-08", "completion_date": "2010-01", "has_results": true, "last_update_posted_date": "2011-03-09", "last_synced_at": "2026-11-10T22:34:12.414Z", "location_count": 20, "location_summary": "Mesa, Arizona • Phoenix, Arizona • Harbor City, California + 17 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Harbor City", "state": "California" }, { "city": "Tustin", "state": "California" }, { "city": "Westlake Village", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00949884" }, { "nct_id": "NCT02246764", "title": "Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ocular Hypertension", "Glaucoma" ], "interventions": [ { "name": "AR-13324 Ophthalmic Solution 0.02%", "type": "DRUG" }, { "name": "AR-13324 Ophthalmic Solution 0.02% BID", "type": "DRUG" }, { "name": "Timolol maleate Ophthalmic Solution 0.5% BID", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Aerie Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "19 Years to 99 Years" }, "enrollment_count": 93, "start_date": "2014-09", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2018-04-06", "last_synced_at": "2026-11-10T22:34:12.414Z", "location_count": 1, "location_summary": "Bedminster, New Jersey", "locations": [ { "city": "Bedminster", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02246764" }, { "nct_id": "NCT01157364", "title": "Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Open-Angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "bimatoprost 20 µg generation 2", "type": "DRUG" }, { "name": "bimatoprost 15 µg generation 2", "type": "DRUG" }, { "name": "bimatoprost 10 µg generation 2", "type": "DRUG" }, { "name": "bimatoprost 6 µg generation 2", "type": "DRUG" }, { "name": "bimatoprost 15 µg generation 1", "type": "DRUG" }, { "name": "bimatoprost 10 µg generation 1", "type": "DRUG" }, { "name": "bimatoprost 0.03%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 109, "start_date": "2010-09-23", "completion_date": "2016-08-09", "has_results": true, "last_update_posted_date": "2020-03-30", "last_synced_at": "2026-11-10T22:34:12.414Z", "location_count": 36, "location_summary": "Artesia, California • La Jolla, California • Los Angeles, California + 31 more", "locations": [ { "city": "Artesia", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Rancho Cordova", "state": "California" }, { "city": "Redding", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01157364" }, { "nct_id": "NCT06388421", "title": "DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pulmonary Hypertension Due to Lung Diseases and Hypoxia", "Pulmonary Hypertension", "Interstitial Lung Disease" ], "interventions": [ { "name": "Prospective study assessments", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "United Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 900, "start_date": "2025-01-23", "completion_date": "2030-11-30", "has_results": false, "last_update_posted_date": "2026-08-26", "last_synced_at": "2026-11-10T22:34:12.414Z", "location_count": 70, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 57 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT06388421" }, { "nct_id": "NCT03640221", "title": "Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes.", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension", "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Ertugliflozin", "type": "DRUG" }, { "name": "Hydrochlorothiazide 12.5mg", "type": "DRUG" }, { "name": "Microneurography", "type": "DEVICE" }, { "name": "SKNA recordings", "type": "OTHER" }, { "name": "Static Handgrip", "type": "OTHER" }, { "name": "Post-handgrip forearm vascular occlusion", "type": "OTHER" }, { "name": "Testing of the Arterial Baroreflex Function", "type": "OTHER" } ], "intervention_types": [ "DRUG", "DEVICE", "OTHER" ], "sponsor": "Cedars-Sinai Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "35 Years to 65 Years" }, "enrollment_count": 0, "start_date": "2018-09-01", "completion_date": "2020-08-31", "has_results": false, "last_update_posted_date": "2020-01-14", "last_synced_at": "2026-11-10T22:34:12.414Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03640221" }, { "nct_id": "NCT01742819", "title": "Advanced Glaucoma Progression Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Primary Open Angle Glaucoma", "Pseudoexfoliative Glaucoma", "Chronic Angle Closure Glaucoma" ], "interventions": [], "intervention_types": [], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 150, "start_date": "2012-05", "completion_date": "2025-12", "has_results": false, "last_update_posted_date": "2025-05-04", "last_synced_at": "2026-11-10T22:34:12.414Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01742819" }, { "nct_id": "NCT01545492", "title": "Testing the Developmental Origins Hypothesis", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Diabetes", "Stroke", "Obesity" ], "interventions": [], "intervention_types": [], "sponsor": "Children's & Women's Health Centre of British Columbia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 626, "start_date": "2012-01", "completion_date": "2019-01", "has_results": false, "last_update_posted_date": "2012-03-06", "last_synced_at": "2026-11-10T22:34:12.414Z", "location_count": 4, "location_summary": "New Haven, Connecticut • Louisville, Kentucky • Camden, New Jersey + 1 more", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Camden", "state": "New Jersey" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT01545492" }, { "nct_id": "NCT04278404", "title": "Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Coronavirus Infection (COVID-19)", "Pulmonary Arterial Hypertension", "Urinary Tract Infections in Children", "Hypertension", "Pain", "Hyperphosphatemia", "Primary Hyperaldosteronism", "Edema", "Hypokalemia", "Heart Failure", "Hemophilia", "Menorrhagia", "Insomnia", "Pneumonia", "Skin Infection", "Arrythmia", "Asthma in Children", "Bronchopulmonary Dysplasia", "Adrenal Insufficiency", "Fibrinolysis; Hemorrhage", "Attention Deficit Hyperactivity Disorder", "Multisystem Inflammatory Syndrome in Children (MIS-C)", "Kawasaki Disease", "Coagulation Disorder", "Down Syndrome" ], "interventions": [ { "name": "The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "0 Years", "maximum_age": "20 Years", "sex": "ALL", "summary": "0 Years to 20 Years" }, "enrollment_count": 5000, "start_date": "2020-03-05", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-08-21", "last_synced_at": "2026-11-10T22:34:12.414Z", "location_count": 49, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Los Angeles, California + 40 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04278404" }, { "nct_id": "NCT03070184", "title": "Race, Natriuretic Peptides and Physiological Perturbations", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Healthy", "Pre Hypertension" ], "interventions": [ { "name": "Exercise capacity VO2 max determination", "type": "OTHER" }, { "name": "Standardized meals", "type": "DIETARY_SUPPLEMENT" }, { "name": "Exercise challenge", "type": "OTHER" }, { "name": "Metoprolol Succinate ER", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DIETARY_SUPPLEMENT", "DRUG" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 80, "start_date": "2017-04-30", "completion_date": "2024-04-30", "has_results": true, "last_update_posted_date": "2025-03-12", "last_synced_at": "2026-11-10T22:34:12.414Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT03070184" }, { "nct_id": "NCT00765648", "title": "Evaluation of Intravenous Cardene(Nicardipine)and Labetalol Use in the Emergency Department", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertensive Urgency" ], "interventions": [ { "name": "nicardipine intravenous", "type": "DRUG" }, { "name": "Labetalol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The Cleveland Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 226, "start_date": "2008-10", "completion_date": "2010-01", "has_results": true, "last_update_posted_date": "2015-01-06", "last_synced_at": "2026-11-10T22:34:12.414Z", "location_count": 2, "location_summary": "Cleveland, Ohio • Houston, Texas", "locations": [ { "city": "Cleveland", "state": "Ohio" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00765648" } ] }